Brief: Zim Laboratories And Globalpharma Announce Collaboration In GCC Region
09/04/2025 12:39
April 9 (Reuters) - Zim Laboratories Ltd ZIML.NS: CO AND GLOBALPHARMA ANNOUNCE COLLABORATION IN GCC REGION ENTERS LICENSE AGREEMENT WITH GLOBALPHARMA GLOBALPHARMA TO COMMERCIALIZE 10 OTF-BASED PRODUCTS BY ZIM Source text: ID:nBSE8BrtsN Further company coverage: ZIML.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia